elicityl-oligotech2024年價格
法國Elicityl 成立于 2002 年，坐落在法國克洛爾,專注于寡糖標準品,現(xiàn)貨庫存產品超400種.主要有以下幾類產品：天然多糖和寡糖類提取物；低聚糖；糖胺聚糖；氨基糖苷類及衍生物；新糖蛋白…。,應用于生物醫(yī)藥，化妝品，保健品和農業(yè)等行業(yè)的科研領域。elicityl-oligotech旨在利用 CNRS（法國領x的學術研究中心）專li，該專li旨在分離作為生物防治植物藥物產品的特定低聚糖。相應的產品稱為PEL101GV，用于增強葡萄園對春季霜凍的天然抵抗力，從而防止凍害條件引起的葉壞死。活性物質七酰氧基葡聚糖是一種從蘋果中提取的高度純化的半纖維素低聚糖，一旦噴灑在葉子上，就會觸發(fā)細胞反應，增強植物的抗凍性。
特別告知：為保證產品質量與良好性能，所以在購買相應產品的同時我司會收取一定量的運輸費用?。?！本次報價有效時間為2024年3月18日---2024年12月20日。
| 貨號 | 品名 | 規(guī)格 | 價格 | 品牌 | 貨期 | 價格來源 |
| GAT114-10mg | Galacturonan oligosaccharides Average DP10/DP15 | 10mg | 4114 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GAT114-50mg | Galacturonan oligosaccharides Average DP10/DP15 | 50mg | 12342 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GAT115-5mg | Galacturonan oligosaccharides Average DP5/DP7 | 5mg | 5142.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU305-90%-5mg | Celloheptaose (>90% HPAEC-PAD) | 5mg | 15427.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU314-99%-100mg | Maltotetraose DP4 (>99% HPLC) | 100mg | 11126.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU315-99%-100mg | Maltopentaose DP5 (>99% HPLC) | 100mg | 11126.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU316-99%-100mg | Maltohexaose DP6 (>99% HPLC) | 100mg | 2057 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU427-100mg | Chitosan oligosaccharides Average DP15-20 | 100mg | 18513 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU427-10mg | Chitosan oligosaccharides Average DP15-20 | 10mg | 4114 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU436-90%-10mg | Chitinhexaose DP6 (>90% RMN) | 10mg | 10285 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU436-90%-25mg | Chitinhexaose DP6 (>90% RMN) | 25mg | 19541.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLU900-1000mg | Pustulan polysaccharide | 1000mg | 15427.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY010-95%-5mg | Lacto-N-tetraose (LNT) (>95% HPLC) | 5mg | 4114 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY031-1-95%-5mg | Blood group H antigen triose type 1 (>95% NMR) | 5mg | 8228 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY031-2-90%-5mg | Blood group H antigen triose type 2 (>90% NMR) | 5mg | 7854 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY035-2-90%-25mg | Blood group A antigen tetraose type 2 (>90% NMR) | 25mg | 82280 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY035-2-90%-5mg | Blood group A antigen tetraose type 2 (>90% NMR) | 5mg | 24684 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY036-1-85%-1mg | Blood group A antigen pentaose type 1 (>85% NMR) | 1mg | 6171 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY036-2-90%-1mg | Blood group A antigen pentaose type 2 (>90% NMR) | 1mg | 6171 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY037-2-90%-1mg | Blood group A antigen hexaose type 2 (>90% NMR) | 1mg | 2431 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY038-2-90%-5mg | Blood group B antigen tetraose type 2 (>90% NMR) | 5mg | 24684 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY039-1-90%-1mg | Blood group B antigen pentaose type 1 (>90% NMR) | 1mg | 4114 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY039-2-90%-1mg | Blood group B antigen pentaose type 2 (>90% NMR) | 1mg | 4114 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY040-2-90%-1mg | Blood group B antigen hexaose type 2 (>90% NMR) | 1mg | 3740 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY040-2-BSA-1mg | Blood group B antigen hexaose type 2 grafted on BSA | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY045-90%-5mg | Lewis b (Leb) tetraose (>90% NMR) | 5mg | 16456 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY050-90%-5mg | Lewis x (Lex) tetraose (>90% NMR) | 5mg | 7854 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY051-75%-1mg | Lewis x (Lex) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 1mg | 5984 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY052-90%-5mg | Lewis y (Ley) pentaose (>90% NMR) | 5mg | 5329.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY054-90%-5mg | Lewis a (Lea) tetraose (>90% NMR) | 5mg | 9069.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-90%-5mg | Lewis b (Leb) pentaose (>90% NMR) | 5mg | 9911 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY061-90%-1mg | Lacto-N-neofucopentaose V (LNnFP-V) (>90% NMR) | 1mg | 3085.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY090-95%-100mg | 3'-Sialyllactose (3'-SL) / GM3 Ganglioside oligosaccharide (>95% NMR) | 100mg | 3740 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY094-BT-C-1mg | GD2 Ganglioside oligosaccharide linked to biotin (Linker-BT C) | 1mg | 63767 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY094-KLH-1mg | GD2 Ganglioside oligosaccharide grafted on KLH | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY100-90%-1mg | GT1a Ganglioside oligosaccharide (>90% NMR) | 1mg | 7199.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY128-90%-1mg | Blood group A antigen pentaose type 4 (>90% NMR) | 1mg | 3459.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY128-90%-5mg | Blood group A antigen pentaose type 4 (>90% NMR) | 5mg | 10285 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY230-90%-5mg | 2’-FucosylLactulose (>90% NMR) | 5mg | 16456 | elicityl-oligotech | 6周 | 上海起發(fā) |
| HGL200-10mg | Glucurono-XyloMannan polysaccharide from Tremella fuciformis | 10mg | 2711.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| LEC101-1mg | LecB (PA-IIL) from Pseudomonas aeruginosa | 1mg | 7947.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| LEC101-BT-1mg | LecB (PA-IIL) from Pseudomonas aeruginosa linked to Biotin | 1mg | 8789 | elicityl-oligotech | 6周 | 上海起發(fā) |
| LEC102-1mg | LecA (PA-IL) from Pseudomonas aeruginosa | 1mg | 7947.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| LEC102-BT-1mg | LecA (PA-IL) from Pseudomonas aeruginosa linked to Biotin | 1mg | 8789 | elicityl-oligotech | 6周 | 上海起發(fā) |
| MAN801-100mg | Acemannan polysaccharide from Aloe vera | 100mg | 26460.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| MAN801-10mg | Acemannan polysaccharide from Aloe vera | 10mg | 4020.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| REF066-10mg | Difucosyllactose (DF-L) Analytical Reference | 10mg | 58811.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| ULV101-1000mg | Ulvan polysaccharide from Enteromorpha sp. (Native grade) | 1000mg | 11313.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| ULV103-100mg | Ulvan polysaccharide from Enteromorpha sp. (Fine grade) | 100mg | 7947.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| XYL100-1000mg | Xylan polysaccharide from Palmaria palmata | 1000mg | 3833.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-GEL-B-5mg | Blood group H antigen disaccharide grafted on gel for affinity chromatography (Linker-GEL B) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-GEL-B-10mg | Blood group H antigen disaccharide grafted on gel for affinity chromatography (Linker-GEL B) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-HSA-1mg | Blood group H antigen disaccharide grafted on HSA | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-HSA-5mg | Blood group H antigen disaccharide grafted on HSA | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-HSA-10mg | Blood group H antigen disaccharide grafted on HSA | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-KLH-1mg | Blood group H antigen disaccharide grafted on KLH | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-KLH-5mg | Blood group H antigen disaccharide grafted on KLH | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-KLH-10mg | Blood group H antigen disaccharide grafted on KLH | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY030-LIPO-A-1mg | Blood group H antigen disaccharide with cyclic di-thiol (Linker-LIPO A) | 1mg | 63767 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-A-5mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT A) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-A-10mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT A) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-B-1mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT B) | 1mg | 63767 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-B-5mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT B) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-B-10mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT B) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-C-1mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT C) | 1mg | 63767 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-C-5mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT C) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-C-10mg | Lewis b (Leb) pentaose linked to biotin (Linker-BT C) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-FLUO-A-1mg | Lewis b (Leb) pentaose linked to biotin and fluorescein (Linker-BT-FLUO A) | 1mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-FLUO-A-5mg | Lewis b (Leb) pentaose linked to biotin and fluorescein (Linker-BT-FLUO A) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-FLUO-A-10mg | Lewis b (Leb) pentaose linked to biotin and fluorescein (Linker-BT-FLUO A) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-STEA-A-1mg | Lewis b (Leb) pentaose linked to biotin and stearic chain (Linker-BT-STEA A) | 1mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-STEA-A-5mg | Lewis b (Leb) pentaose linked to biotin and stearic chain (Linker-BT-STEA A) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-BT-STEA-A-10mg | Lewis b (Leb) pentaose linked to biotin and stearic chain (Linker-BT-STEA A) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-CRM197-1mg | Lewis b (Leb) pentaose grafted on CRM197 | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-CRM197-5mg | Lewis b (Leb) pentaose grafted on CRM197 | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-DBCO-A-5mg | Lewis b (Leb) pentaose with DBCO (Linker-DBCO A) | 5mg | 59653 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-DBCO-A-10mg | Lewis b (Leb) pentaose with DBCO (Linker-DBCO A) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-DBT-A-1mg | Lewis b (Leb) pentaose linked to desthiobiotin (Linker-DBT-A) | 1mg | 63767 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY056-DBT-A-5mg | Lewis b (Leb) pentaose linked to desthiobiotin (Linker-DBT-A) | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-HSA-5mg | Isoglobopentaose (iGb5) grafted on HSA | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-HSA-10mg | Isoglobopentaose (iGb5) grafted on HSA | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-KLH-1mg | Isoglobopentaose (iGb5) grafted on KLH | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-KLH-5mg | Isoglobopentaose (iGb5) grafted on KLH | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-KLH-10mg | Isoglobopentaose (iGb5) grafted on KLH | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-B-5mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 B) | 5mg | 59653 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-B-10mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 B) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-C-5mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 C) | 5mg | 59653 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-C-10mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 C) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-D-5mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 D) | 5mg | 59653 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-NH2-D-10mg | Isoglobopentaose (iGb5) with free terminal amine (Linker-NH2 D) | 10mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-OVA-1mg | Isoglobopentaose (iGb5) grafted on OVA | 1mg | 71995 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY073-OVA-5mg | Isoglobopentaose (iGb5) grafted on OVA | 5mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY131-YNE-A-50mg | Stage-Specific Embryonic Antigen-4 hexaose (SSEA-4 hexaose) with terminal alkyne (Linker-CΞCH A) | 50mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY131-YNE-A-100mg | Stage-Specific Embryonic Antigen-4 hexaose (SSEA-4 hexaose) with terminal alkyne (Linker-CΞCH A) | 100mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-1mg | Forssman antigen pentaose (>90% NMR) | 1mg | 2898.5 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-5mg | Forssman antigen pentaose (>90% NMR) | 5mg | 8789 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-10mg | Forssman antigen pentaose (>90% NMR) | 10mg | 16082 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-25mg | Forssman antigen pentaose (>90% NMR) | 25mg | 37026 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-50mg | Forssman antigen pentaose (>90% NMR) | 50mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
| GLY132-90%-100mg | Forssman antigen pentaose (>90% NMR) | 100mg | 詢價 | elicityl-oligotech | 6周 | 上海起發(fā) |
（*此為部分產品價格完整價格請下載文件）
關鍵詞：elicityl-oligotech、天然多糖和寡糖類提取物、低聚糖、糖胺聚糖、氨基糖苷
